In an experimental murine T-cell acute lymphoblastic leukemia (T-ALL) model, Trib2−/− mice had reduced latency in vivo, which associated with impaired MAP kinase (MAPK) activation. The gene discussed is TRIB2; the disease is T-cell acute lymphoblastic leukemia.